Published:
|
|
Is there any treatment?
The most common treatment for Leigh's disease is thiamine or Vitamin B1. In patients who have a deficiency of pyruvate dehydrogenase
enzyme complex, a high-fat, low-carbohydrate diet may be recommended. Oral sodium bicarbonate or sodium citrate may also be
prescribed to manage lactic acidosis. Experimental protocols are currently using dichloroacetate to treat patients with lactic
acidosis.
What is the prognosis?
The prognosis for individuals with Leigh's disease is poor. Individuals who lack mitochondrial complex IV activity and those
with pyruvate dehydrogenase deficiency tend to have the worst prognosis and die within a few years. Those with partial deficiencies
have a better prognosis, and may live to be 6 or 7 years of age. Some have survived to their mid-teenage years.
What research is being done?
The NINDS supports and encourages a broad range of basic and clinical research on neurogenetic disorders such as Leigh's disease.
The goal of this research is to understand what causes these disorders and then to apply these findings to new ways to diagnose,
treat, and prevent them.